Explore 3 Stock Ideas & Industry Insights Download Free Report

News

TOMI Environmental Solutions (NASDAQ: TOMZ) Secures $450,000 Contract for SteraMist System at Rhode Island University

TOMI Environmental Solutions, Inc.® (NASDAQ:TOMZ), a leader in disinfection and decontamination solutions, has announced a significant contract valued at approximately $450,000 to install a SteraMist iHP Custom Engineered System (CES) at a leading university in Rhode Island. This contract was secured through TOMI's distributor, …

Team Kalkine | 24 March 2025

QuantaSing Group (NASDAQ: QSG) Makes Strategic Investment in Shenzhen Yiqi Culture to Enter Pop Toys Market

QuantaSing Group Limited (NASDAQ:QSG), a prominent lifestyle solution provider, has entered into definitive agreements to invest in Shenzhen Yiqi Culture Co., Ltd. ("Letsvan"). Letsvan, a leading PRC-based company, specializes in IP incubation, copyright commercialization, and the promotion and sales of pop toys. This strategic …

Team Kalkine | 24 March 2025

Teledyne FLIR Defense (NYSE: TDY) Secures $7.8 Million Contract with METCO for LVSS Deployment in Saudi Arabia

Teledyne FLIR Defense, a division of Teledyne Technologies Incorporated (NYSE: TDY), has announced a $7.8 million contract with Middle East Task Company (METCO). The agreement will see Teledyne FLIR Defense provide its cutting-edge Lightweight Vehicle Surveillance System (LVSS) to a prominent military entity in …

Team Kalkine | 24 March 2025

Abivax SA (Nasdaq: ABVX) Sets Sights on Full Enrollment of ABTECT Trial and Key Data in 2025

Abivax SA (Nasdaq:ABVX), a clinical-stage biotechnology company, has announced its financial results for the year ending December 31, 2024. The results were approved by the Company's Board of Directors on March 20, 2025, and will be filed with the French and U.S. securities authorities …

Team Kalkine | 24 March 2025

Opthea (NASDAQ: OPT) Announces COAST Phase 3 Trial Results and Development Funding Agreement Review

Opthea Limited (NASDAQ:OPT), a clinical-stage biopharmaceutical company, has announced the results of its global Phase 3 COAST (Combination OPT-302 with Aflibercept Study) trial, which evaluated the combination therapy of sozinibercept and aflibercept for the treatment of wet age-related macular degeneration (wet AMD). The trial …

Team Kalkine | 24 March 2025

Global Market Dynamics: U.S. Federal Reserve Anticipation, Tariff Expectations, and Geopolitical Impacts on Commodities

U.S. stock index futures rose sharply on Monday, March 24, 2025, as reports indicated that upcoming U.S. trade tariffs under President Donald Trump may be more targeted and less severe than previously feared, alleviating concerns over their economic impact. At 06:00 ET, Dow Jones …

Team Kalkine | 24 March 2025

Topgolf Callaway (NYSE:MODG) Faces Net Loss in FY24, Forecasts Decreased Revenues and EBITDA in 2025

Topgolf Callaway Brands Corp. (NYSE:MODG)is a dynamic golf and active lifestyle company offering a variety of products and experiences. Its family of brands includes Odyssey, Jack Wolfskin, Callaway Golf, World Golf Tour, Topgolf, TravisMathew, Toptracer, OGIO, and others, providing golf equipment, apparel, and entertainment …

Team Kalkine | 23 March 2025